EP3303564
AÐFERÐIR VIÐ IN VITRO SÉRHÆFINGU DÓPAMÍNTAUGAFRUMNA (MDA) Í MIÐHEILA
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
1.6.2016EP published:
23.2.2022EP application number:
16804350.3
EP translation filed:
19.4.2022Grant published:
15.5.2022EPO information:
European Patent Register
Max expiry date:
31.5.2036Expiry date:
31.5.2026Next due date:
30.6.2026
Title in English:
METHODS OF IN VITRO DIFFERENTIATION OF MIDBRAIN DOPAMINE (MDA) NEURONSLanguage of the patent:
English
Timeline
Today
1.6.2016EP application
23.2.2022EP Publication
19.4.2022Translation submitted
15.5.2022Registration published
31.5.2026Expires
Owner
Name:
Memorial Sloan Kettering Cancer CenterAddress:
1275 York Avenue, New York, NY 10065, US
Inventor
Name:
STUDER, LorenzAddress:
New York, NY 10065, US
Name:
IRION, StefanAddress:
New York, NY 10023, US
Name:
TOMISHIMA, MarkAddress:
Chatham, NJ 07928, US
Name:
KRIKS, SonjaAddress:
San Francisco, CA 94102, US
Agent
Name:
Novagraaf BrevetsAddress:
Bâtiment O2, 2 rue Sarah Bernhardt CS90017, FR
Priority
Number:
201562169379 PDate:
1.6.2015Country:
US
Number:
201562169444 PDate:
1.6.2015Country:
US
Classification
Categories:
A61K 35/30, A61K 35/545, A61P 25/16, C12N 5/00, C12N 5/071, C12N 5/0793, C12N 5/0797
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 27.7.2022
Expires: 31.5.2023
Payer: Árnason Faktor ehf.
Number: 8
Paid: 24.5.2023
Expires: 31.5.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 7.5.2024
Expires: 31.5.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 16.5.2025
Expires: 31.5.2026
Payer: Árnason Faktor ehf.